Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | L-Glutamine | HCID 5961 | — |
| Reactant | PMA ionomycin | HCID 131724875 | — |
| Reactant | HCID 178431920 | HCID 178431920 | — |
| Solvent | Dimethyl Sulfoxide | HCID 679 | — |
| Product | Ionomycin | HCID 6912226 | — |
Reaction Steps
The assay for PMA/ionomycin-stimulated PBMC proliferation was performed in 96-well flat-bottomed microtitre plates. Compounds were prepared as 10 mM stock solutions in dimethyl sulfoxide. A 50-fold dilution of this was prepared in RPMI and serial dilutions were prepared from this solution. 10 μl of the 50-fold diluted stock, or dilutions of it, were added to the well to give concentrations in the assay starting at 9.5 μM and going down. Into each well was placed 1×105 PBMC, prepared from human peripheral blood from a single donor, in RPMI1640 medium supplemented with 10% human serum, 2 mM glutamine and penicillin/streptomycin. Phorbol myristate acetate (PMA) (0.5 ng/ml final concentration) and ionomycin (500 ng/ml final concentration) were added to these cells in supplemented RPMI1640 medium (as above) so that the final volume of the assay was 0.2 ml. The cells were incubated at 37° C. in a humidified atmosphere at 5% carbon dioxide for 72 hours. 3H-Thymidine (0.5 μCi) was added for the final 6 hours of the incubation. The level of radioactivity incorporated by the cells was then determined and this is a measure of proliferation.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07384951B2 |
|---|
| Source dataset | uspto-grants-2008_06 |
|---|
| ORD ID | ord-b1164291d09840ae840904c1478b46dd |
|---|
| Source note | uspto-grants-2008_06 |
|---|